Clin2
NCT07528027Likely a fitRecruiting

Testing HRS-7535 for High Blood Pressure and Extra Weight

Hypertension With Overweight or Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests whether a new medicine called HRS-7535 can help lower blood pressure in people who are overweight or have obesity. You would take it alongside your current blood pressure medications (or as a new treatment) to see if it works better at controlling your blood pressure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
648 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • Be between 18 and 70 years old
  • Have high blood pressure (systolic between 140–169 mmHg or diastolic between 90–109 mmHg)
  • Have a BMI of 24 or higher (a measure of body weight relative to height)
  • Be either untreated for high blood pressure or on a stable dose of certain blood pressure medicines for at least 30 days
  • Not have a known secondary cause of high blood pressure (a specific underlying condition causing it)
  • Not have a history of heart failure with reduced ejection fraction or recent heart procedures

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06820099Recruiting· Phase 2
A drug for heart failure with obesity

This trial tests an oral drug called HRS-7535 for people with a certain type of heart failure (where the heart pumps normally but doesn't relax properly) and who also have obesity. It aims to see if the drug can improve symptoms and daily function.

Beijing, Beijing Municipality
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07551167Recruiting· Phase 1
Safety Study of HRS-5765 in Healthy Adults

This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.

Beijing, Beijing Municipality
NCT06974851Recruiting· Phase 3
Study of HRS9531 for sleep apnea and obesity

This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.

Beijing, Beijing Municipality
NCT07670884Recruiting· Phase 3
Study of HRS9531 for weight loss in overweight or obese adults

This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.

Zhengzhou, Henan
NCT07150962Recruiting· Phase 1
Testing a new version of an obesity treatment pill

This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.

Hefei, Anhui

Hear when a new Hypertension With Overweight or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.